Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Obesity and other associated complications promote the development and the progression of osteoarthritis. The subcutaneous and abdominal fat release several factors that alter bone and the cartilage. The role of the marrow fat in close connection with bone has not been defined yet, whereas cellular and animal models indicate that this fat depot modifies bone and cartilage.
The aim of the study is to define if the marrow fat produces more joint-altering factors by comparison with subcutaneous fat. This fat depot can be characterized from removed pieces during the prosthetic surgery of the knee. Measuring before surgery the body weight, waist and hip circumferences, blood pressure, glucose, insulin and lipids in blood will also allow to determine if obesity and/or type 2 diabetes make this fat more dangerous for the joint. Such research will allow the elaboration of new therapeutic strategies in osteoarthritis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
with refusal to participate to the study
more than 85-year-old
with bone pathologies other than osteoarthritis or osteoporosis
with active infection
with evolving cancer
with haematopoietic pathologies such as haemoglobin pathologies
with thyroid pathologies
with type 1 diabetes
with anti-osteoporotic treatments (bisphosphonates, strontium ranelate, teriparatide, denosumab) except calcium and vitamin D supplementation or hormone replacement.
with replacement of prosthesis
with previous surgery at the surgery site
--with a current participation to another study
with guardianship
with deprived liberty
45 participants in 1 patient group
Loading...
Central trial contact
Gilles Pasquier, MD,PhD; Stéphanie LUCAS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal